Hydroxyapatite formed on/in agarose gel induces activation of blood coagulation and platelets aggregation.

We reported earlier that hydroxyapatite (HA) formed on/in agarose gels (HA/agarose) produced by alternate soaking process is a bone-filling material possessing osteoconductive and hemostatic effects. This process could allow us to make bone-like apatite that was formed on/in organic polymer hydrogel matrices. Here, we investigated the mechanism of hemostasis induced by HA/agarose and found that HA/agarose, but not agarose or HA powder, significantly shortened activated partial thromboplastin time (APTT). While HA/agarose did not show significant platelet aggregation, it markedly enhanced adenosine diphosphate (ADP)-induced platelet aggregation. Moreover, Western blot analysis revealed selective adsorption of vitronectin onto HA/agarose. We also observed marked differences between HA powder and HA/agarose in their XRD patterns. The crystallinity of HA powder was much higher compared to that of HA/agarose. Furthermore, 50-100 nm of tube-form aggregations was observed in HA powder on the other hand 100-200 nm of particles was observed in HA/agarose by SEM observation. Thus 100-200 nm of low crystallized particles on the surface structure of HA/agarose may play an important role in hemostasis. Our results demonstrated a crucial role of HA/agarose in the mechanism of hemostasis and suggested a potential role for HA/agarose as a bone-grafting material.

[1]  M. Akashi,et al.  Apatite formed on/in agarose gel as a bone-grafting material in the treatment of periodontal infrabony defect. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[2]  K. Preissner The role of vitronectin as multifunctional regulator in the hemostatic and immune systems , 1989, Blut.

[3]  M. Kazatchkine,et al.  Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries , 2004, Virchows Archiv A.

[4]  M. Akashi,et al.  Osteoconductive and hemostatic properties of apatite formed on/in agarose gel as a bone-grafting material. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[5]  M. Yamakuchi,et al.  Membrane cholesterol but not putative receptors mediates anandamide‐induced hepatocyte apoptosis , 2003, Hepatology.

[6]  M. Matsusaki,et al.  Novel Guglielmi detachable coils (GDCs) for the treatment of brain aneurysms. In vitro study of hydroxyapatite coating on Pt plate as GDCs model. , 2003, Journal of biomedical materials research. Part B, Applied biomaterials.

[7]  E. Fu,et al.  Chitosan enhances platelet adhesion and aggregation. , 2003, Biochemical and biophysical research communications.

[8]  T. Podor,et al.  Incorporation of Vitronectin into Fibrin Clots , 2002, The Journal of Biological Chemistry.

[9]  N. Gibran,et al.  Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice. , 2000, Surgery.

[10]  M. Akashi,et al.  Apatite formation on/in hydrogel matrices using an alternate soaking process (III): effect of physico-chemical factors on apatite formation on/in poly(vinyl alcohol) hydrogel matrices. , 1999, Journal of biomaterials science. Polymer edition.

[11]  M. Akashi,et al.  Apatite formation on/in hydrogel matrices using an alternate soaking process: II. Effect of swelling ratios of poly(vinyl alcohol) hydrogel matrices on apatite formation. , 1999, Journal of biomaterials science. Polymer edition.

[12]  N. Gibran,et al.  Changes in matrix composition during the growth and regression of human hemangiomas. , 1998, The Journal of surgical research.

[13]  M. Akashi,et al.  Hydroxyapatite Formation on/in Poly(vinyl alcohol) Hydrogel Matrices Using a Novel Alternate Soaking Process , 1998 .

[14]  D. Seiffert,et al.  Role of vitronectin and its receptors in haemostasis and vascular remodeling. , 1998, Thrombosis research.

[15]  C. P. Sharma,et al.  Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. , 1997, Journal of biomedical materials research.

[16]  K. Preissner,et al.  Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. , 1995, Experimental eye research.

[17]  T. Fujinami,et al.  Poster abstractAscorbic acid as a protective agent against peroxidation of LDL , 1994 .

[18]  R. Sato,et al.  Accumulation of vitronectin in atherosclerotic lesions where lipids deposited. , 1994, Journal of atherosclerosis and thrombosis.

[19]  C. Misch,et al.  BONE‐GRAFTING MATERIALS IN IMPLANT DENTISTRY , 1993, Implant dentistry.

[20]  K. Shewmake,et al.  Augmentation of the Craniofacial Skeleton with Porous Hydroxyapatite Granules , 1993, Plastic and reconstructive surgery.

[21]  S. Low,et al.  Bioactive ceramics for periodontal treatment: comparative studies in the Patus monkey. , 1992, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[22]  M. Meenaghan,et al.  Osteogenesis of hydroxyapatite and tricalcium phosphate used as a bone substitute. , 1992, The International journal of oral & maxillofacial implants.

[23]  J. Glowacki,et al.  Tissue response to composite ceramic hydroxyapatite/demineralized bone implants. , 1990, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[24]  E. Podack,et al.  Vitronectin binds to activated human platelets and plays a role in platelet aggregation. , 1990, The Journal of clinical investigation.

[25]  W. Hiatt,et al.  Restoration of mandibular continuity defects using combinations of hydroxylapatite and autogenous bone: microscopic observations. , 1990, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[26]  O. Beirne,et al.  Effect of hydroxylapatite, tricalcium phosphate, and collagen on the healing of defects in the rat mandible. , 1988, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[27]  R. Lebo,et al.  cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. , 1986, The Journal of clinical investigation.

[28]  M. Jarcho Biomaterial aspects of calcium phosphates. Properties and applications. , 1986, Dental clinics of North America.

[29]  J. Thomas,et al.  Hydroxylapatite as an alloplastic graft in the treatment of human periodontal osseous defects. , 1985, Journal of periodontology.

[30]  G. Longenecker The Platelets : physiology and pharmacology , 1985 .

[31]  Michael Jarcho,et al.  Calcium phosphate ceramics as hard tissue prosthetics. , 1981, Clinical orthopaedics and related research.

[32]  H. Aoki,et al.  Biocompatibility of apatite ceramics in mandibles. , 1979, Biomaterials, medical devices, and artificial organs.